Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 3 | 2 | — | — | 6 |
Ocular hypertension | D009798 | EFO_1001069 | H40.0 | 1 | 3 | 2 | — | — | 6 |
Glaucoma | D005901 | EFO_0000516 | H40 | 1 | 3 | 2 | — | — | 6 |
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | 1 | 3 | 2 | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Sepetaprost |
INN | sepetaprost |
Description | Sepetaprost is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target prostaglandin F2-alpha receptor. |
Classification | Small molecule |
Drug class | prostaglandins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)OC(=O)CCC[C@H]1CC[C@H]2[C@H](C[C@@H](O)[C@@H]2/C=C/[C@@H](O)COc2cc(F)ccc2F)OC1 |
PDB | — |
CAS-ID | 1262873-06-2 |
RxCUI | — |
ChEMBL ID | CHEMBL4297633 |
ChEBI ID | — |
PubChem CID | 50902259 |
DrugBank | DB12043 |
UNII ID | 79O7855J4G (ChemIDplus, GSRS) |